As Bcr-Abl signals downstream to PLK1 [135], the PLK1 inhibitor BI2536 was studied in combination with vorinostat in CML cell lines and primary cells [136]. Here, PLK1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.